COMPLETION OF THE COMPULSORY ACQUISITION PERIOD AND INITIATION OF THE COMPULSORY ACQUISITION OF THE SHARES HELD BY THE REMAINING MINORITY SHAREHOLDERS OF EVERFUEL A/S
Reading Time: 5 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH-AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS
Thales to Enhance Vehicle Access With Reliable and Secure Contactless Solutions
Reading Time: 4 minutes MEUDON, France: Car industry players can rely on Thales to provide digital and physical solutions that improve car access experiences, while ensuring data security. Thales’s offer encompasses a digital car key solution, whose implementation follows the Car Connectivity Consortium1
Top Auto Leaders Get Together at the World’s Longest Running Program on Vehicle After Sales Service
Reading Time: 7 minutes The 10th edition of IVASS – India Vehicle After Sales Summit, the world’s longest-running program on Vehicle After Sales Service, was recently held in New Delhi. Organized annually by the World Auto Forum (WAF), the summit brought together top leaders from the country’s After Sales Service
Andersen Global Expands Capabilities with Addition of Valora
Reading Time: 2 minutes San Francisco, United States: Andersen Global continues to broaden its service offerings through a Collaboration Agreement with Valora, an independent firm specializing in providing custom solutions for both private and institutional clients globally. Valora operates with offices in
BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic’s PyroGlutamate-amyloid-beta antibody program
Reading Time: 3 minutes Stockholm, Sweden, December 19, 2024 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that it has entered into a global exclusive license agreement with Bristol Myers Squibb (NYSE: BMY) for BioArctic’s PyroGlutamate-amyloid-beta (PyroGlu-Aβ) antibody program, including BAN1503 and BAN2803, whereof
MBK Partners and Young Poong Expand Stake in Korea Zinc to 46.7% of Voting Shares
Reading Time: 2 minutes Seoul, South Korea: MBK Partners, through its special-purpose company, Korea Corporate Investment Holdings Co., Ltd., has acquired an additional 1.13% stake in Korea Zinc. This latest acquisition increases MBK Partners and Young Poong’s combined stake in Korea Zinc
Ellevio acquires Markbygden Net Väst, continues northern Sweden expansion
Reading Time: 3 minutes Swedish energy company Ellevio acquires Markbygden Net Väst AB, an electricity grid company with significant importance for the green economy in the northern Swedish region of Norrbotten. The deal marks the next step in Ellevio’s efforts to establish itself in the
EmpowerHER24 of SHELeads – On the Mission to Transfoming Future of Women Entrepreneurs
Reading Time: 2 minutes Pune, Maharashtra, India: SHELeadIndia is proud to announce the conclusion of EmpowerHER24, the second edition of its flagship event aimed at empowering women entrepreneurs. EmpowerHER24 brought together not only hundreds of aspiring & leading women entrepreneurs from and around Pune, but
Quick and Easy Personal Loans with OneScore App
Reading Time: 4 minutes Personal loans offer a swift financial solution for various needs, providing borrowers quick access to funds anytime, anywhere. These loans ensure fast processing and approval, often within hours. Borrowers benefit from flexibility, as no collateral is required, and the application process is straightforward.
Novotech Publishes Report on the Global COVID-19 Clinical Trial Landscape, Highlighting Key Trends, Therapeutic Advancements, and Challenges in Drug Development
Reading Time: 3 minutes San Francisco, United States: Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released an in-depth report “COVID-19: Global Clinical Trial Landscape 2024.” This report delivers